Clinical Trial

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

Name: A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. — clinical trial record (NCT07555392)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CHIKV/II-III

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

A Seamless Phase II/III, Observer-blind, Multi-centre, Randomized Clinical Trial to Evaluate Immunogenicity and Safety of BBV87, an Inactivated Chikungunya Virus Vaccine in Healthy Subjects 12-65 Years of Age

Trial Details

NCT Number	NCT07555392
Lead Sponsor	Bharat Biotech International Limited
Conditions	Active Immunisation for Chikungunya Virus Infection
Enrollment	1,000 participants
Start Date	2026-04-20
Primary Completion	2026-09-20 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-29